Jennifer Robertson, PharmD, BCPS

Jennifer Robertson, PharmD, BCPS

  • Medication Outcomes and Safety Officer
  • Director, Medication-Use Safety Residency

Board Certification(s)

  • BCPS


  • PharmD – University of Tennessee College of Pharmacy, Memphis, Tennessee

Post-Graduate Training

  • Specialty Residency in Drug Information - Methodist Healthcare, Memphis, Tennessee

Focused Area of Practice

  • Medication Use Policy
  • Medication Safety

Research Interests

  • Medication Event Prevention
  • Clinical Decision Support/Alert Fatigue

St. Jude Committee Service

  • Pharmacy and Therapeutics Committee
  • Medication Use Safety Team
  • Patient Safety Event Evaluation Team
  • Quality Patient Safety Council

Pharmacy Organizations/Committee Service

  • American Society of Health System Pharmacists
    • Educational Steering Committee, Section of Inpatient Care Practitioners
    • Committee on Nominations, Section of Inpatient Care Practitioners
    • Curriculum Vitae Reviewer Program
  • Tennessee Pharmacists Association
  • Medication Safety Officers Society
  • Mid-South College of Clinical Pharmacy

Selected Publications

McDaniel RB, Burlison JD, Baker DK, Hasan M, Robertson J, Hartford C, et al. Alert dwell time: introduction of a measure to evaluate interruptive clinical decision support alerts. J Am Med Inform Assoc. 2015 Oct 24. [Epub ahead of print].

Call RJ, Burlison JD, Robertson JJ, Scott JR, Baker DK, Rossi MG, Howard SC, Hoffman JM. Adverse drug event detection in pediatric oncology and hematology patients: Using medication triggers to identify patient harm in a specialized pediatric patient population. J Pediatr 165(3):447-52, 2014.

Amarshi, N, Hoffman JM, Robertson, JJ. 2006 Drug & Data Updates. In: The APhA Complete Review for Pharmacy. 4th ed. Gourley DR and Eoff JC, eds. New York: Castle Connolly Graduate Medical Publishing, Ltd. 2007:827-866.

Jones JR. Drug Use Policy and Drug Information Services. In: Clinical Pharmacy Services: Successful Practices in Community Hospitals. Koch KE and Lobo BL, eds. Kansas City, MO: American College of Clinical Pharmacy; 2005: 147-152.

Brown SJ, Eichner SF, Jones JR. Nebulized morphine for relief of dyspnea due to chronic lung disease. Ann Pharmacother 39(6):1088-1092, 2005.

Moore ML, Eichner SF, Jones JR. Treating functional impairment of autism with selective serotonin-reuptake inhibitors. Ann Pharmacother 38(9):1515-9, 2004.

Last update: January 2018